en.Wedoany.com Reported - Recently, Malaysia's private healthcare group IHH Healthcare released its first-quarter results for 2026. On a constant currency basis and excluding special items, the group's core revenue increased by 16% year-on-year to $1.6 billion; on a reported basis, revenue grew by 4% year-on-year to $1.6 billion, while net profit attributable to shareholders rose by 3% year-on-year to 528 million ringgit.
IHH Healthcare's growth is primarily driven by stable demand across its multi-market hospital network. As a large private healthcare services group headquartered in Malaysia, IHH operates hospitals and medical service networks in markets including Malaysia, Singapore, Turkey, India, Greater China, and Europe, under brands such as Pantai, Gleneagles, Mount Elizabeth, Parkway, Fortis, and Acibadem. The first-quarter results indicate that the group continues to benefit from demand for high-quality medical services, an increased share of acute and complex cases, and price adjustments made to counter inflation. Revenue growth for healthcare service groups often depends not only on inpatient volume but also on case mix, specialist capabilities, the proportion of day care, the recovery of medical tourism, and revenue intensity per inpatient. By operating across multiple markets simultaneously, IHH can buffer the impact of healthcare policies, patient flow shifts, or exchange rate fluctuations in any single market through performance in other regions.
Hospital and medical services remain the group's core pillar. In the first quarter, revenue from this segment rose to approximately 6.24 billion ringgit, while EBITDA increased to about 1.39 billion ringgit.
By region, Malaysia's operations continue to be driven by medical tourism and high-acuity cases. Although inpatient numbers declined, revenue per inpatient increased, indicating that case mix and service prices are supporting revenue. India's operations are expanding through growth in inpatient volume and higher revenue per inpatient, reflecting ongoing demand for mid-to-high-end private healthcare in the local market. Operations in Turkey and Europe maintained growth amid demand from foreign patients, price adjustments, and a high-inflation environment, serving as an important buffer against pressures in other regions. Singapore's operations face challenges such as changes in public healthcare utilization patterns, payer constraints, and fluctuations in some medical tourism demand. The group will need to stabilize patient flow through high-value specialist services, non-inpatient care, corporate client partnerships, and tailored insurance products.
This financial report reflects a shift in the growth logic of private healthcare groups in Asia and emerging markets. In the past, hospital group expansion relied more on adding beds, acquiring hospitals, and increasing inpatient volume; now, growth depends more on cross-regional networks, specialist depth, complex case management capabilities, day-care models, digital operations, and cost control. IHH's earlier acquisition of Bayindir Healthcare also contributed to revenue growth in the first quarter, indicating that it continues to expand its service network through regional acquisitions. At the same time, the translation impact of a strong Malaysian ringgit reminds the market that the operational performance of multinational healthcare groups must be assessed by observing both local currency business growth and financial fluctuations under the reporting currency.
IHH Healthcare's core revenue and core profit maintained growth in the first quarter, suggesting that demand for its basic medical services remains resilient. Future variables will focus on the recovery of Singapore operations, the sustainability of growth in India and Turkey, cost control amid medical inflation, changes in the proportion of complex cases, and the impact of payer policies in various markets on the revenue intensity of private hospitals. For the regional healthcare industry, IHH's performance also shows that large private hospital groups are transitioning from single-hospital operations to comprehensive competition based on cross-market medical networks, specialist capabilities, and operational efficiency.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
